Principles and Biomedical Application of Graphene Family Nanomaterials.

Iruthayapandi Selestin Raja, Saifullah Lone, Dong-Wook Han, Suck Won Hong

Abstract read

In one paragraph

Article in Advances in experimental medicine and biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Iruthayapandi Selestin RajaBIO-IT Fusion Technology Research Institute, Pusan National University, Busan, South Korea.

Saifullah LoneBIO-IT Fusion Technology Research Institute, Pusan National University, Busan, South Korea.

Dong-Wook HanDepartment of Cogno-Mechatronics Engineering, College of Nanoscience and Nanotechnology, Pusan National University, Busan, South Korea.

Suck Won HongDepartment of Cogno-Mechatronics Engineering, College of Nanoscience and Nanotechnology, Pusan National University, Busan, South Korea. swhong@pusan.ac.kr.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Two-dimensional graphene family nanomaterials (GFNs) are extensively studied by the researchers for their quantum size effect, large surface area, numerous reactive functional sites, and biocompatibility. The hybrid materials of GFNs exhibit an increased level of mechanical strength, optical, electronic, and catalytic activity due to their incorporation. The application of GFNs in the energy, environment, electric and electronic, personal care, and health sectors is abundant, which is not only by their unique physicochemical properties but also by their ease and large production by various synthetic approaches and economically inexpensiveness. Their general biomedical applications include bioimaging, biosensing, drug delivery, tissue engineering, killing the microbes, and demolishing the cancer tumor. The first chapter of this book describes definitions, synthetic methods, unique properties, and biomedical applications of GFNs, including graphene, graphene oxide, and reduced graphene oxide.

Indexed as

GraphiteNanostructuresPharmaceutical PreparationsDrug Delivery SystemsTissue EngineeringGraphitePharmaceutical PreparationsBiomedical applicationsGraphene family nanomaterialsPrinciplesSynthetic approaches

Identifiers

PMID35175609

DOI10.1016/B978-0-12-815341-3.00007-9

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.